 |
 |
 |
 |
 |
 |
|
If you feel your organisation could benefit from our expertise please don't hesitate to contact us
|
Services
The sensitive nature of the surface properties of an active pharmaceutical ingredient (API) to the performance properties of a formulation, warrants the need for a greater degree of characterisation of the API to ensure consistency in stability and efficacy of a drug product.While conventional bulk analytical tools may indirectly highlight changes to the physicochemical properties of the API, their influence on interfacial interactions between drug substances, carrier(s) and components of the device, which govern the overall behaviour of a formulation, are not well understood. Nanopharm Ltd has developed a suite of services to directly characterise the influence of subtle variations in the physico-chemical properties of the API to complex interfacial interactions within solid-state and suspension based formulations. These API screening tools allow informed decisions to be made throughout the research and development process and to facilitate protection measures and optimisation controls in aiding early phase development and reducing late phase failures. Our key services are:
|